Multidrug resistance in new TB patients
Part of Infections clinical trials.
This trial is for people newly diagnosed with tuberculosis (TB) and looks at how TB bacteria can become resistant to multiple drugs. It will help doctors understand which treatments work best for new TB patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have just been told you have tuberculosis (TB).
- Your TB was found by testing a sample of your sputum (phlegm) or other body fluid under a microscope.
- You have never been treated for TB before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new “triple-dose” set of medicines to treat people whose tuberculosis (TB) has come back in the lungs. If you qualify, the goal is to improve cure rates and reduce the chance of TB returning again.
This trial tests how quickly two antibiotics (tedizolid vs linezolid) can kill tuberculosis germs in the lungs after a first TB infection is suspected. It may help doctors learn which option works faster and safely in the early treatment phase.
This study compares a new, fast test (GeneXpert) to standard lab methods for finding TB bacteria and checking if they are resistant to a key antibiotic (rifampicin). It is open to adults who are suspected of having TB for the first time.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.